Downregulation of the adenosine a2b receptor by RNA interference inhibits hepatocellular carcinoma cell growth

Hong-Jun Xiang1, Fu-Lu Chai, De-Sheng Wang

  • 1Department of Hepatobiliary Surgery, Lanzhou General Hospital, Lanzhou Military Area Command of Chinese People's Liberation Army, 98 XiaoXiHu Road, Lanzhou 730050, China.

ISRN Oncology
|November 18, 2011
PubMed

Insights

Silencing adenosine A2b receptor (A2bR) in liver cancer cells (HepG2) using siRNA effectively inhibited tumor growth. This A2bR gene silencing blocked the cell cycle, offering a potential new therapy for hepatocellular carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • The adenosine A2b receptor (A2bR) role in HCC progression is not fully understood.
  • Targeting specific receptors presents a therapeutic opportunity for cancer treatment.

Purpose of the Study:

  • To investigate the biological effects of adenosine A2b receptor (A2bR) on human hepatocellular carcinoma cells.
  • To evaluate the potential of A2bR gene silencing as a therapeutic strategy for HCC.

Main Methods:

  • Transient transfection of HepG2 cells with three A2bR siRNA constructs.
  • Establishment of a stable HepG2 cell line expressing siRNA targeting A2bR.
  • Assessment of A2bR mRNA and protein levels.
  • In vitro tumor cell growth inhibition assays.
  • Cell cycle analysis using flow cytometry (FCM).

Main Results:

  • A2bR siRNA successfully reduced A2bR mRNA and protein levels in HepG2 cells.
  • Targeted RNA interference significantly inhibited hepatocellular carcinoma cell growth in vitro.
  • Flow cytometry revealed a significant increase in G0/G1 phase cells (89.56% ± 3.15%) in the A2bR siRNA group compared to controls (56.19% ± 1.58%).

Conclusions:

  • Silencing adenosine A2b receptor expression in HepG2 cells effectively suppresses cell growth by blocking the cell cycle.
  • Downregulation of A2bR gene expression via RNA interference presents a promising novel therapeutic approach for hepatocellular carcinoma.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...